Liver Cancer  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT02069041: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Completed
1b
8
RoW
Ramucirumab, IMC-1121B, LY3009806, FOLFOX4, FOLFOX4 (leucovorin + fluorouracil + oxaliplatin)
Eli Lilly and Company
Carcinoma, Hepatocellular
09/16
09/16
NCT00003427: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Completed
1
36
US
irinotecan hydrochloride, oxaliplatin
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Anal Cancer, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer
04/02
04/02
NCT00101270: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Completed
1
24
US
irinotecan hydrochloride, Campto, Camptosar, CPT-11, irinotecan, U-101440E, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP
National Cancer Institute (NCI)
Childhood Burkitt Lymphoma, Childhood Central Nervous System Germ Cell Tumor, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Medulloblastoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor, Recurrent Childhood Visual Pathway Glioma, Recurrent Colon Cancer, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Melanoma, Recurrent Nasopharyngeal Cancer, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific
09/07
 
NCT00507585: Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin

Completed
1
63
US
Fluorouracil, 5-FU, Adrucil, Efudex, 5-fluorouracil, Avastin, Bevacizumab, Leucovorin, Oxaliplatin
M.D. Anderson Cancer Center
Liver Cancer, Advanced Solid Tumors
01/10
01/10
NCT00005860: Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Completed
1
US
floxuridine, leucovorin calcium, oxaliplatin
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Cancer
 
 
NCT00861783: Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma

Completed
1
16
US
irinotecan and ON 01910.Na, camptothecin-11, irinotecan HCl, Camptosar, CPT-11, diaminocyclohexane oxalatoplatinum, rigosertib sodium, oxaliplatin and ON 01910.Na, Eloxatin, oxaloplatinum, oxalatoplatin
Onconova Therapeutics, Inc.
Hepatoma, Advanced Solid Tumor
07/11
07/11
NCT01042691: Isolated Liver Perfusion With Oxaliplatin

Completed
1
10
US
Oxaliplatin
David Bartlett, The Pittsburgh Foundation, Sanofi
Unresectable Colorectal Liver Metastases
11/11
11/11
NCT00557557: Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases

Checkmark
Apr 2013 - Apr 2013: 
Completed
1
14
US
Drug: 5-FU, Drug: Oxaliplatin
David Bartlett, National Institutes of Health (NIH), National Cancer Institute (NCI)
Colorectal Liver Metastases
03/12
08/14
NCT00987766: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

Completed
1
28
US
erlotinib hydrochloride, gemcitabine hydrochloride, oxaliplatin, laboratory biomarker analysis
Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI)
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Pancreatic Cancer, Periampullary Adenocarcinoma, Small Intestine Cancer
07/13
10/16
NCT00980239: HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Completed
1
115
US
Irinotecan, CPT-11, Camptosar, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF, Oxaliplatin, Eloxatin, Cetuximab, C225, Erbitux, IMC-C225
M.D. Anderson Cancer Center
Liver Cancer, Advanced Cancer
08/15
08/15

Download Options